Advertisement

Topics

BioInvent buys Merck single-use tech to up mAb capacity

12:06 EDT 21 Apr 2017 | BioPharma-Reporter

BioInvent International AB has acquired a range of different single-use bioreactors from Germany’s Merck to up monoclonal antibody (mAb) capacity at its plant in Lund, Sweden.

Original Article: BioInvent buys Merck single-use tech to up mAb capacity

NEXT ARTICLE

More From BioPortfolio on "BioInvent buys Merck single-use tech to up mAb capacity"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...